Growth Metrics

Summit Therapeutics (SMMT) Amortizatization of Intangibles (2017 - 2025)

Historic Amortizatization of Intangibles for Summit Therapeutics (SMMT) over the last 10 years, with Q2 2025 value amounting to $1.0 million.

  • Summit Therapeutics' Amortizatization of Intangibles fell 3626.17% to $1.0 million in Q2 2025 from the same period last year, while for Sep 2025 it was $1.6 million, marking a year-over-year decrease of 6807.56%. This contributed to the annual value of $2.6 million for FY2024, which is 3388.77% up from last year.
  • As of Q2 2025, Summit Therapeutics' Amortizatization of Intangibles stood at $1.0 million, which was down 3626.17% from $3.0 million recorded in Q1 2025.
  • Over the past 5 years, Summit Therapeutics' Amortizatization of Intangibles peaked at $3.0 million during Q1 2025, and registered a low of -$2.4 million during Q4 2024.
  • In the last 5 years, Summit Therapeutics' Amortizatization of Intangibles had a median value of $257000.0 in 2021 and averaged $572133.3.
  • As far as peak fluctuations go, Summit Therapeutics' Amortizatization of Intangibles crashed by 122980.77% in 2024, and later soared by 63781.09% in 2025.
  • Quarter analysis of 5 years shows Summit Therapeutics' Amortizatization of Intangibles stood at $340000.0 in 2021, then tumbled by 113.53% to -$46000.0 in 2022, then surged by 552.17% to $208000.0 in 2023, then plummeted by 1229.81% to -$2.4 million in 2024, then surged by 143.53% to $1.0 million in 2025.
  • Its Amortizatization of Intangibles stands at $1.0 million for Q2 2025, versus $3.0 million for Q1 2025 and -$2.4 million for Q4 2024.